BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index

  Concert Pharma announced that it has been selected for addition to the NASDAQ Biotechnology Index effective prior to the market open on Monday, December 18, 2017.

  December 13, 2017

   · 

  1 min read
• Spectrum Pharmaceuticals Highlights Two Oral Presentations on FOLOTYN (pralatrexate injection) at the 59th Annual Meeting of the American Society of Hematology (ASH)

  In the 29 patients evaluable for response, the investigator assessed objective response (OR) and complete response (CR) rates were 90% and 66%, respectively.

  December 13, 2017

   · 

  8 min read
• Pharm Country

  The Medicines Company to Host Investor Day on January 23, 2018

  The Medicines Company announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City.

  December 13, 2017

   · 

  2 min read
• Genetown

  Eleven Biotherapeutics Announces Chief Scientific Officer to Chair a Session at the Antibody Engineering and Therapeutics Meeting

  Eleven Biotherapeutics announced that Dr. Gregory Adams, Chief Scientific Officer, will chair a session focused on antibody drug conjugates and fusion proteins at the Antibody Engineering and Therapeutics Meeting in San Diego, CA.

  December 13, 2017

   · 

  4 min read
• Drug Development

  MabVax Therapeutics Announces Completion of Enrollment and Dosing in Initial Cohort of MVT-1075 Radioimmunotherapy Phase I Trial for the Treatment of Pancreatic, Colon and Lung Cancers

  This Phase 1 first-in-human clinical trial is an open-label, multi-center study evaluating the safety and efficacy of MVT-1075 in approximately 22 patients with CA19-9 positive malignancies in the U.S.

  December 13, 2017

   · 

  6 min read
• BIOREM Announces Orders Totalling $7M and Order Backlog of $17M

  The orders are for air emission abatement projects in China and North America.

  December 13, 2017

   · 

  1 min read
• Business

  Immunomic Therapeutics Welcomes Key Thought Leader in Immuno-Oncology, Dr. Drew Pardoll, to Its Scientific Advisory Board

  Dr. Pardoll is a world-renowned cancer researcher in the field of immuno-oncology.

  December 13, 2017

   · 

  5 min read
• Business

  Arrakis Therapeutics Announces Exclusive License to RNA-targeted Small Molecule Technology From the University of Pennsylvania

  The license allows utilization of technology related to families of compounds that selectively bind specific nucleic acid structures, called three-way junctions.

  December 13, 2017

   · 

  3 min read
• Biotech Beach

  Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS™

  Sirenas announced that it has received a new grant from the Bill & Melinda Gates Foundation to advance ATLANTIS.

  December 13, 2017

   · 

  3 min read
• Biotech Beach

  Capricor Therapeutics Announces Issuance of Key U.S. Patent on Exosome Technology

  Capricor today announced that the U.S. Patent and Trademark Office has issued U.S. Patent 9,828,603, which includes composition of matter claims covering cardiosphere-derived cell exosomes.

  December 13, 2017

   · 

  5 min read